U.S. stocks on the move: Palantir, Haemonetics
HAE•Palantir climbed after Goldman Sachs turned bullish. Haemonetics surged 17.2% as CSL plans to move all its U.S. plasma centers to Haemonetics devices.
1. Shares move higher
Palantir shares climbed after Goldman Sachs turned bullish. Haemonetics was among the NYSE’s top percentage gainers, rising 17.2% after CSL said it plans to move all its U.S. plasma centers to Haemonetics devices.
